176 related articles for article (PubMed ID: 17368035)
21. Evidence towards the role of arylamine N-acetyltransferase in Mycobacterium smegmatis and development of a specific antiserum against the homologous enzyme of Mycobacterium tuberculosis.
Payton M; Gifford C; Schartau P; Hagemeier C; Mushtaq A; Lucas S; Pinter K; Sim E
Microbiology (Reading); 2001 Dec; 147(Pt 12):3295-302. PubMed ID: 11739761
[TBL] [Abstract][Full Text] [Related]
22. Antimicrobial activity of recombinant mature bovine neutrophil β-defensin 4 on mycobacterial infection.
Kang JJ; Lyu Y; Zhao DM; Tian LH; Yin XM; Yang LF; Teng KD; Zhou XM
Int J Tuberc Lung Dis; 2015 Jun; 19(6):711-6. PubMed ID: 25946365
[TBL] [Abstract][Full Text] [Related]
23. The effect of sulindac on arylamine N-acetyltransferase activity in Pseudomonas aeruginosa.
Lo HH; Hsieh SE; Chung JG
Microbios; 1998; 93(376):159-68. PubMed ID: 9721671
[TBL] [Abstract][Full Text] [Related]
24. Mycobacterium bovis bacillus Calmette-Guérin infection induces TLR2-dependent peroxisome proliferator-activated receptor gamma expression and activation: functions in inflammation, lipid metabolism, and pathogenesis.
Almeida PE; Silva AR; Maya-Monteiro CM; Töröcsik D; D'Avila H; Dezsö B; Magalhães KG; Castro-Faria-Neto HC; Nagy L; Bozza PT
J Immunol; 2009 Jul; 183(2):1337-45. PubMed ID: 19561094
[TBL] [Abstract][Full Text] [Related]
25. Novel small-molecule inhibitors of arylamine N-acetyltransferases: drug discovery by high-throughput screening.
Westwood IM; Kawamura A; Russell AJ; Sandy J; Davies SG; Sim E
Comb Chem High Throughput Screen; 2011 Feb; 14(2):117-24. PubMed ID: 21118080
[TBL] [Abstract][Full Text] [Related]
26. Anti-mycobacterial activity of a bis-sulfonamide.
Wilkinson BL; Bornaghi LF; Wright AD; Houston TA; Poulsen SA
Bioorg Med Chem Lett; 2007 Mar; 17(5):1355-7. PubMed ID: 17258454
[TBL] [Abstract][Full Text] [Related]
27. Structural and functional characterization of an arylamine N-acetyltransferase from the pathogen Mycobacterium abscessus: differences from other mycobacterial isoforms and implications for selective inhibition.
Cocaign A; Kubiak X; Xu X; Garnier G; Li de la Sierra-Gallay I; Chi-Bui L; Dairou J; Busi F; Abuhammad A; Haouz A; Dupret JM; Herrmann JL; Rodrigues-Lima F
Acta Crystallogr D Biol Crystallogr; 2014 Nov; 70(Pt 11):3066-79. PubMed ID: 25372695
[TBL] [Abstract][Full Text] [Related]
28. Oligosaccharides as inhibitors of mycobacterial arabinosyltransferases. Di- and trisaccharides containing C-3 modified arabinofuranosyl residues.
Cociorva OM; Gurcha SS; Besra GS; Lowary TL
Bioorg Med Chem; 2005 Feb; 13(4):1369-79. PubMed ID: 15670944
[TBL] [Abstract][Full Text] [Related]
29. Anti-mycobacterial activity of five plant species used as traditional medicines in the Western Cape Province (South Africa).
Bamuamba K; Gammon DW; Meyers P; Dijoux-Franca MG; Scott G
J Ethnopharmacol; 2008 May; 117(2):385-90. PubMed ID: 18384988
[TBL] [Abstract][Full Text] [Related]
30. The ability of Warburgia salutaris extracts to protect against crystalline silica-induced cell injury.
Leshwedi M; Steenkamp V; Dutton M; Gulumian M
Hum Exp Toxicol; 2008 Nov; 27(11):827-35. PubMed ID: 19244290
[TBL] [Abstract][Full Text] [Related]
31. Effect of solvents on rat liver cytosolic acetyl CoA:arylamine N-acetyltransferase activity in vitro.
Svensson CK; Ware JA
Res Commun Chem Pathol Pharmacol; 1993 Jan; 79(1):121-4. PubMed ID: 8434128
[TBL] [Abstract][Full Text] [Related]
32. Schiff base conjugates of p-aminosalicylic acid as antimycobacterial agents.
Patole J; Shingnapurkar D; Padhye S; Ratledge C
Bioorg Med Chem Lett; 2006 Mar; 16(6):1514-7. PubMed ID: 16413184
[TBL] [Abstract][Full Text] [Related]
33. Synthesis and antimycobacterial evaluation of benzofurobenzopyran analogues.
Prado S; Janin YL; Saint-Joanis B; Brodin P; Michel S; Koch M; Cole ST; Tillequin F; Bost PE
Bioorg Med Chem; 2007 Mar; 15(5):2177-86. PubMed ID: 17208445
[TBL] [Abstract][Full Text] [Related]
34. Inhibition of Mycobacterium tuberculosis secretory serine protease blocks bacterial multiplication both in axenic culture and in human macrophages.
Upadhye V; Majumdar A; Gomashe A; Joshi D; Gangane N; Thamke D; Mendiratta D; Harinath BC
Scand J Infect Dis; 2009; 41(8):569-76. PubMed ID: 19479636
[TBL] [Abstract][Full Text] [Related]
35. Search for antimycobacterial constituents from a Tibetan medicinal plant, Gentianopsis paludosa.
Yeung MF; Lau CB; Chan RC; Zong Y; Che CT
Phytother Res; 2009 Jan; 23(1):123-5. PubMed ID: 19107824
[TBL] [Abstract][Full Text] [Related]
36. Exploration of 5-(5-nitrothiophen-2-yl)-4,5-dihydro-1H-pyrazoles as selective, multitargeted antimycobacterial agents.
Agre N; Khambete M; Maitra A; Gupta A; Munshi T; Bhakta S; Degani M
Chem Biol Drug Des; 2020 Jan; 95(1):192-199. PubMed ID: 31560814
[TBL] [Abstract][Full Text] [Related]
37. Anti-tubercular screening of natural products from Colombian plants: 3-methoxynordomesticine, an inhibitor of MurE ligase of Mycobacterium tuberculosis.
Guzman JD; Gupta A; Evangelopoulos D; Basavannacharya C; Pabon LC; Plazas EA; Muñoz DR; Delgado WA; Cuca LE; Ribon W; Gibbons S; Bhakta S
J Antimicrob Chemother; 2010 Oct; 65(10):2101-7. PubMed ID: 20719764
[TBL] [Abstract][Full Text] [Related]
38. Membrane-active antimicrobial peptides and human placental lysosomal extracts are highly active against mycobacteria.
Jena P; Mishra B; Leippe M; Hasilik A; Griffiths G; Sonawane A
Peptides; 2011 May; 32(5):881-7. PubMed ID: 21396418
[TBL] [Abstract][Full Text] [Related]
39. Luteolin inhibits the growth and arylamine N-acetyl-transferase activity in Neisseria gonorrhoeae.
Tsou MF; Chen GW; Hung CF; Yeh FT; Chang HL; Lu HF; Chung JG
Microbios; 2001; 104(408):87-97. PubMed ID: 11297015
[TBL] [Abstract][Full Text] [Related]
40. HPLC-SPE-NMR characterization of sesquiterpenes in an antimycobacterial fraction from Warburgia salutaris.
Clarkson C; Madikane EV; Hansen SH; Smith PJ; Jaroszewski JW
Planta Med; 2007 Jun; 73(6):578-84. PubMed ID: 17486536
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]